Teprotumumab for Active Thyroid Eye Disease
- PMID: 32402170
- DOI: 10.1056/NEJMc2002754
Teprotumumab for Active Thyroid Eye Disease
Comment in
-
Teprotumumab for Active Thyroid Eye Disease. Reply.N Engl J Med. 2020 May 14;382(20):1959-1960. doi: 10.1056/NEJMc2002754. N Engl J Med. 2020. PMID: 32402172 No abstract available.
Comment on
-
Teprotumumab for the Treatment of Active Thyroid Eye Disease.N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434. N Engl J Med. 2020. PMID: 31971679 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources